IconOVir Bio
Company

IconOVir Bio

Biotechnology Research 4570 Executive Drive 10 employees
Employees
10
Contacts
3
Emails
3
Phones
2

IconOVir Bio Overview

Headquarters
4570 Executive Drive
Industry
Biotechnology Research
Employees
10
Funding
77.0M
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About IconOVir Bio

IconOVir Bio is a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer. Our proprietary oncolytic virus platform is based on technology developed by scientific founder Clodagh O’Shea, Ph.D., of the Salk Institute. It is designed to address key limitations of first- and second-generation oncolytic viruses.

IconOVir Bio Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
2
50.0% coverage

IconOVir Bio Org Chart

Sample employees and titles
Name Title Contact
Nicole Van De Leuv Principal at Two River
Email Phone
Helen S. Kim
Email
Jakob Loven, Phd
View
Mark Mccamish President & Chief Executive Officer
Email Phone

Compare Similar Companies to IconOVir Bio